Loading…
Enzymatic Characterization of Fructose 1,6-Bisphosphatase II from Francisella tularensis, an Essential Enzyme for Pathogenesis
The glpX gene from Francisella tularensis encodes for the class II fructose 1,6-bisphosphatase (FBPaseII) enzyme. The glpX gene has been verified to be essential in F. tularensis , and the inactivation of this gene leads to impaired bacterial growth on gluconeogenic substrates. In the present work,...
Saved in:
Published in: | Applied biochemistry and biotechnology 2017-12, Vol.183 (4), p.1439-1454 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | The
glpX
gene from
Francisella tularensis
encodes for the class II fructose 1,6-bisphosphatase (FBPaseII) enzyme. The
glpX
gene has been verified to be essential in
F. tularensis
, and the inactivation of this gene leads to impaired bacterial growth on gluconeogenic substrates. In the present work, we have complemented a
∆glpX
mutant of
Escherichia coli
with the
glpX
gene of
F. tularensis
(FTF1631c). Our complementation work independently verifies that the
glpX
gene (FTF1631c) in
F. tularensis
is indeed an FBPase and supports the growth of the
ΔglpX E. coli
mutant on glycerol-containing media. We have performed heterologous expression and purification of the
glpX
encoded FBPaseII in
F. tularensis
. We have confirmed the function of
glpX
as an FBPase and optimized the conditions for enzymatic activity. Mn
2+
was found to be an absolute requirement for activity, with no other metal substitutions rendering the enzyme active. The kinetic parameters for this enzyme were found as follows: K
m
11 μM, V
max
2.0 units/mg, k
cat
1.2 s
−1
, k
cat
/K
m
120 mM
−1
s
−1
, and a specific activity of 2.0 units/mg. Size exclusion data suggested an abundance of a tetrameric species in solution. Our findings on the enzyme’s properties will facilitate the initial stages of a structure-based drug design program targeting this essential gene of
F. tularensis
. |
---|---|
ISSN: | 0273-2289 1559-0291 |
DOI: | 10.1007/s12010-017-2512-6 |